WUSTL spinout Wugen has collected $172m in a series B round to progress its pipeline targeting several cancer indications.

Wugen, a US-based oncology therapy developer spun out of Washington University in St Louis, closed a $172m series B round co-led by Abingworth and Tybourne Capital Management on Thursday. Alexandria Venture Investments, the venture capital arm of life sciences real estate investment trust Alexandria Real Estate Equities, took part in the round, as did financial…

The rest of this content is only accessible to University Venturing: News, Data, and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.